Epidemiology of pulmonary embolism diagnosis and management among United States emergency departments over an eight-year period
- 10 September 2024
- journal article
- research article
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 85, 158-162
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Epidemiology of back pain visits and medication usage among United States emergency departments from 2016 to 2023The American Journal of Emergency Medicine, 2024
- Managing Pulmonary EmbolismAnnals of Emergency Medicine, 2023
- Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High–risk Pulmonary EmbolismJAMA Cardiology, 2022
- Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO studyAmerican Heart Journal, 2022
- Apixaban has superior effectiveness and safety compared to rivaroxaban in patients with commercial healthcare coverage: A population‐based analysis in response to CVS 2022 formulary changesAmerican Journal of Hematology, 2022
- Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial FibrillationJAMA, 2021
- Thrombotic complications of COVID-19The American Journal of Emergency Medicine, 2021
- Time Trends in Pulmonary Embolism in the United StatesArchives of internal medicine (1960), 2011
- Simplification of the Pulmonary Embolism Severity Index for Prognostication in Patients With Acute Symptomatic Pulmonary EmbolismArchives of internal medicine (1960), 2010
- Obesity as a risk factor in venous thromboembolismThe American Journal of Medicine, 2005